Does MEROPENEM Cause Product use in unapproved indication? 385 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 385 reports of Product use in unapproved indication have been filed in association with MEROPENEM (Meropenem). This represents 2.8% of all adverse event reports for MEROPENEM.
385
Reports of Product use in unapproved indication with MEROPENEM
2.8%
of all MEROPENEM reports
131
Deaths
197
Hospitalizations
How Dangerous Is Product use in unapproved indication From MEROPENEM?
Of the 385 reports, 131 (34.0%) resulted in death, 197 (51.2%) required hospitalization, and 56 (14.5%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEROPENEM. However, 385 reports have been filed with the FAERS database.
What Other Side Effects Does MEROPENEM Cause?
Drug ineffective (2,802)
Off label use (1,572)
Condition aggravated (706)
Pyrexia (669)
Multiple organ dysfunction syndrome (655)
Drug reaction with eosinophilia and systemic symptoms (626)
Septic shock (613)
Drug resistance (539)
Acute kidney injury (522)
Rash (437)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which MEROPENEM Alternatives Have Lower Product use in unapproved indication Risk?
MEROPENEM vs MEROPENEM ANHYDROUS
MEROPENEM vs MESALAMINE
MEROPENEM vs MESNA
MEROPENEM vs METAMIZOLE
MEROPENEM vs METARAMINOL